Literature DB >> 9590700

Plasma D-dimer level in patients with colorectal cancer: its role as a tumor marker.

M Oya1, Y Akiyama, T Yanagida, S Akao, H Ishikawa.   

Abstract

The purpose of this study was to explore the relationship between the preoperative plasma D-dimer (DD) levels and the tumor pathology of colorectal cancer. The plasma DD levels were measured preoperatively in 108 patients with colorectal cancer, and then were correlated with the tumor pathology and stage. The diagnostic value of the DD levels for the tumor stage was then compared with that of the preoperative carcinoembryonic antigen (CEA) levels. The preoperative DD levels were higher in patients with either a large-sized tumor or a tumor showing deep wall penetration. Lymph-node metastasis, lymphatic invasion, hepatic metastasis, and peritoneal dissemination were all associated with higher DD levels. A stepwise increase in the median DD level was found with the tumor stage. The preoperative DD levels also significantly correlated with CEA levels. When a cutoff value of 0.6 microg/ml was used in the DD assay, the sensitivity and specificity for Dukes C or D cancer were 67.2% and 64.0%, and those for Dukes D cancer were 91.3% and 57.6%, respectively. Although the DD assay was less specific, its diagnostic value in the preoperative staging of colorectal cancer was comparable to that of the CEA assay. The measurement of the preoperative DD level is thus considered to be useful for the preoperative staging of colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9590700     DOI: 10.1007/s005950050144

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  22 in total

1.  The activation of coagulation by extracts of mucus: a possible pathway of intravascular coagulation accompanying adenocarcinomas.

Authors:  G F Pineo; E Regoeczi; M W Hatton; M C Brain
Journal:  J Lab Clin Med       Date:  1973-08

2.  Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer.

Authors:  H J Wanebo; B Rao; C M Pinsky; R G Hoffman; M Stearns; M K Schwartz; H F Oettgen
Journal:  N Engl J Med       Date:  1978-08-31       Impact factor: 91.245

3.  The use of preoperative plasma CEA levels for the Stratification of patients after curative resection of colorectal cancers.

Authors:  R Goslin; G Steele; J Macintyre; R Mayer; P Sugarbaker; K Cleghorn; R Wilson; N Zamcheck
Journal:  Ann Surg       Date:  1980-12       Impact factor: 12.969

4.  Characterization of plasminogen activators from normal human breast and colon and from breast and colon carcinomas.

Authors:  J D Tissot; J Hauert; F Bachmann
Journal:  Int J Cancer       Date:  1984-09-15       Impact factor: 7.396

5.  The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer.

Authors:  C G Moertel; J R O'Fallon; V L Go; M J O'Connell; G S Thynne
Journal:  Cancer       Date:  1986-08-01       Impact factor: 6.860

6.  Plasminogen activator secretion of human tumors in short-term organ culture, including a comparison of primary and metastatic colon tumors.

Authors:  G Markus; S M Camiolo; S Kohga; J M Madeja; A Mittelman
Journal:  Cancer Res       Date:  1983-11       Impact factor: 12.701

7.  Factor X-activating activity in patients with colorectal carcinoma.

Authors:  R Dover; N L Goeting; I Taylor; O S Roath; J L Francis
Journal:  Br J Surg       Date:  1987-12       Impact factor: 6.939

8.  Tumor necrosis factor and coagulopathy in patients with prostate cancer.

Authors:  J Nakashima; M Tachibana; M Ueno; S Baba; H Tazaki
Journal:  Cancer Res       Date:  1995-11-01       Impact factor: 12.701

9.  Preoperative evaluation of D-dimer and CA 125 levels in differentiating benign from malignant ovarian masses.

Authors:  A Gadducci; U Baicchi; R Marrai; M Ferdeghini; R Bianchi; V Facchini
Journal:  Gynecol Oncol       Date:  1996-02       Impact factor: 5.482

10.  The plasmin system in human adenocarcinomas and their metastases. A comparative immunofluorescence study.

Authors:  P Burtin; G Chavanel; J André-Bougaran; A Gentile
Journal:  Int J Cancer       Date:  1987-02-15       Impact factor: 7.396

View more
  12 in total

1.  Prognostic value of plasma d-dimer levels in patients with glioblastoma multiforme - Results from a pilot study.

Authors:  Matthias Hoke; Karin Dieckmann; Renate Koppensteiner; Martin Schillinger; Christine Marosi; Wolfgang Mlekusch
Journal:  Wien Klin Wochenschr       Date:  2011-03-28       Impact factor: 1.704

2.  D-dimer predicts postoperative recurrence and prognosis in patients with liver metastasis of colorectal cancer.

Authors:  Akira Watanabe; Kenichiro Araki; Norihumi Harimoto; Norio Kubo; Takamichi Igarashi; Norihiro Ishii; Takahiro Yamanaka; Kei Hagiwara; Hiroyuki Kuwano; Ken Shirabe
Journal:  Int J Clin Oncol       Date:  2018-03-24       Impact factor: 3.402

3.  Cyclophosphamide, epirubicin and fluorouracil chemotherapy-induced alteration of haemostasis markers in breast cancer patients.

Authors:  Zhi Wang; Chengxue Dang; Kun Zhu; Yong Zhang; Dongmin Chang; Peng Xia; Yongchun Song; Kang Li
Journal:  Mol Clin Oncol       Date:  2015-06-24

4.  Quantitative estimation of Serum Fibrinogen Degradation Product levels in Oral Premalignant and Malignant lesions.

Authors:  Leena Gharat; Govind P Rathod; Shilpa Kandalgaonkar
Journal:  J Int Oral Health       Date:  2013-10-26

5.  Advantages of the AMDL-ELISA DR-70 (FDP) assay over carcinoembryonic antigen (CEA) for monitoring colorectal cancer patients.

Authors:  Andrea L Small-Howard; Holden Harris
Journal:  J Immunoassay Immunochem       Date:  2010

6.  Comparison of the serum fibrin-fibrinogen degradation products with cytokeratin 19 fragment as biomarkers in patients with lung cancer.

Authors:  Hee Jin So; Seok-Il Hong; Jin Kyung Lee; Yoon Hwan Chang; Sun Jung Kang; Young Jun Hong
Journal:  Biomed Rep       Date:  2014-07-11

7.  Coagulation tests show significant differences in patients with breast cancer.

Authors:  Faruk Tas; Leyla Kilic; Derya Duranyildiz
Journal:  Tumour Biol       Date:  2014-03-05

8.  D-dimer levels as a prognostic factor for determining oncological outcomes in musculoskeletal sarcoma.

Authors:  Takeshi Morii; Kazuo Mochizuki; Takashi Tajima; Shoichi Ichimura; Kazuhiko Satomi
Journal:  BMC Musculoskelet Disord       Date:  2011-11-01       Impact factor: 2.362

Review 9.  Clinicopathological significance of stromal variables: angiogenesis, lymphangiogenesis, inflammatory infiltration, MMP and PINCH in colorectal carcinomas.

Authors:  Xiao-Feng Sun; Hong Zhang
Journal:  Mol Cancer       Date:  2006-10-06       Impact factor: 27.401

10.  Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer.

Authors:  Luc Y Dirix; R Salgado; R Weytjens; C Colpaert; I Benoy; P Huget; P van Dam; A Prové; J Lemmens; P Vermeulen
Journal:  Br J Cancer       Date:  2002-02-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.